Human Genome Epidemiology Literature Finder
Records 1 - 26 (of 26 Records) |
Query Trace: Lung Neoplasms and ERCC5[original query] |
---|
Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. International journal of cancer. Journal international du cancer 2005 Sep 116 (5): 768-73. Shen Min, Berndt Sonja I, Rothman Nathaniel, Demarini David M, Mumford Judy L, He Xingzhou, Bonner Matthew R, Tian Linwei, Yeager Meredith, Welch Robert, Chanock Stephen, Zheng Tongzhang, Caporaso Neil, Lan Qi |
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006 Mar 27 (3): 560-7. Zienolddiny Shanbeh, Campa Daniele, Lind Helge, Ryberg David, Skaug Vidar, Stangeland Lodve, Phillips David H, Canzian Federico, Haugen Aa |
Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Human molecular genetics 2007 Oct 16 (19): 2333-40. Matakidou Athena, el Galta Rachid, Webb Emily L, Rudd Matthew F, Bridle Helen, , Eisen Tim, Houlston Richard |
Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. Carcinogenesis 2007 Aug 28 (8): 1731-9. Michiels Stefan, Danoy Patrick, Dessen Philippe, Bera Alex, Boulet Thomas, Bouchardy Christine, Lathrop Mark, Sarasin Alain, Benhamou Simo |
Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. International journal of medical sciences 2007 4 (2): 59-71. Kiyohara Chikako, Yoshimasu Kouic |
Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. International journal of cancer. Journal international du cancer 2008 Nov 123 (9): 2095-104. Chang Jeffrey S, Wrensch Margaret R, Hansen Helen M, Sison Jennette D, Aldrich Melinda C, Quesenberry Charles P, Seldin Michael F, Kelsey Karl T, Kittles Rick A, Silva Gabriel, Wiencke John |
XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer. Acta biochimica et biophysica Sinica 2009 May 41 (5): 429-35. Feng Jifeng, Sun Xinchen, Sun Ning, Qin Shukui, Li Fan, Cheng Hongyan, Chen Baoan, Cao Yuandong, Ma Jun, Cheng Lu, Lu Zuhong, Ji Jiazhong, Zhou Yingfe |
A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. Journal of the National Cancer Institute 2009 Jan 101 (1): 24-36. Vineis Paolo, Manuguerra Maurizio, Kavvoura Fotini K, Guarrera Simonetta, Allione Alessandra, Rosa Fabio, Di Gregorio Alessandra, Polidoro Silvia, Saletta Federica, Ioannidis John P A, Matullo Giusep |
Role of DNA repair gene polymorphisms in the efficiency of platinum-based adjuvant chemotherapy for non-small cell lung cancer. Molecular diagnosis & therapy 2011 Jun 15 (3): 159-66. Mathiaux Juliette, Le Morvan Valérie, Pulido Marina, Jougon Jacques, Bégueret Hugues, Robert Jacqu |
XRCC1 Arg399Gln was associated with repair capacity for DNA damage induced by occupational chromium exposure. BMC research notes 2012 5 (1): 263. Zhang Xuhui, Zhang Xuan, Zhang Lei, Chen Qing, Yang Zhangping, Yu Jingmin, Fu Hong, Zhu Yim |
Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. International journal of molecular epidemiology and genetics 2012 3 (1): 1-17. Sakoda Lori C, Loomis Melissa M, Doherty Jennifer A, Julianto Liberto, Barnett Matt J, Neuhouser Marian L, Thornquist Mark D, Weiss Noel S, Goodman Gary E, Chen C |
Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer. Anti-cancer drugs 2012 Nov . He C, Duan Z, Li P, Xu Q, Yuan Y |
Association between single nucleotide polymorphisms (SNPs) and toxicity of advanced non-small-cell lung cancer patients treated with chemotherapy. PloS one 2012 7 (10): e48350. Zhang Ling, Gao Guanghui, Li Xuefei, Ren Shengxiang, Li Aiwu, Xu Jianfang, Zhang Jie, Zhou Caic |
Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer letters 2014 Oct 353 (2): 160-6. Sullivan Ivana, Salazar Juliana, Majem Margarita, Pallarés Cinta, Del Río Elisabeth, Páez David, Baiget Montserrat, Barnadas Agus |
Role of XRCC1 and ERCC5 polymorphisms on clinical outcomes in advanced non-small cell lung cancer. Genetics and molecular research : GMR 2014 13 (2): 3100-7. Liu D, Wu J, Shi G Y, Zhou H F, Yu |
Genetic association between ERCC5 rs17655 polymorphism and lung cancer risk: evidence based on a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jun 35 (6): 5613-8. Liang Yujia, Deng Jun, Xiong Ying, Wang Songping, Xiong W |
Haplotype and diplotype analyses of variation in ERCC5 transcription cis-regulation in normal bronchial epithelial cells. Physiological genomics 2016 May physiolgenomics.00021.2016. Zhang Xiaolu, Crawford Erin L, Blomquist Thomas M, Khuder Sadik A, Yeo Jiyoun, Levin Albert M, Willey James |
The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs. Scientific reports 2016 Dec 6 39217. Rulli Eliana, Guffanti Federica, Caiola Elisa, Ganzinelli Monica, Damia Giovanna, Garassino Marina C, Piva Sheila, Ceppi Lorenzo, Broggini Massimo, Marabese Mir |
Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer. Scientific reports 2017 Sep 7 (1): 11785. Song Xiao, Wang Shiming, Hong Xuan, Li Xiaoying, Zhao Xueying, Huai Cong, Chen Hongyan, Gao Zhiqiang, Qian Ji, Wang Jiucun, Han Baohui, Bai Chunxue, Li Qiang, Wu Junjie, Lu Da |
Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer. Pathology, research and practice 2017 Nov . Pérez-Ramírez Cristina, Cañadas-Garre Marisa, Alnatsha Ahmed, Villar Eduardo, Delgado Juan Ramón, Calleja-Hernández Miguel Ángel, Faus-Dáder María Jo |
Polymorphisms in DNA repair genes in lung cancer patients living in a coal-mining region. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2019 Nov 28 (6): 522-528. Minina Varvara I, Bakanova Marina L, Soboleva Olga A, Ryzhkova Anastasia V, Titov Ruslan A, Savchenko Yana A, Sinitsky Maxim Yu, Voronina Elena N, Titov Victor A, Glushkov Andrey |
Genetic evaluation of the variants using MassARRAY in non-small cell lung cancer among North Indians. Scientific reports 2021 May 11 (1): 11291. Bhat Gh Rasool, Sethi Itty, Bhat Amrita, Verma Sonali, Bakshi Divya, Sharma Bhanu, Nazir Muddasser, Dar Khursheed A, Abrol Deepak, Shah Ruchi, Kumar Rake |
Role of ERCC5 polymorphisms in non?small cell lung cancer risk and responsiveness/toxicity to cisplatin?based chemotherapy in the Chinese population. Oncology reports 2021 Jan . Li Miao, Chen Rong, Ji Baoyan, Fan Chunmei, Wang Guanying, Yue Chenli, Jin Guoqu |
Variants of ERCC5 and the outcome of platinum-based regimens in non-small cell lung cancer: a prospective cohort study. Medical oncology (Northwood, London, England) 2022 Jul 39 (10): 152. Abdalkhalek Esraa S, Wakeel Lamia M El, Nagy Ahmed A, Sabri Nagwa |
The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese. Journal of Cancer 2022 1 13 (2): 517-526. Lan Xueling, Li Ying, Wu Yefeng, Li Xia, Xu L |
Role of rs873601 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy. Biomedicines 2023 12 11 (12): . Ting Zou, Jun-Yan Liu, Qun Qin, Jie Guo, Wen-Zhi Zhou, Xiang-Ping Li, Hong-Hao Zhou, Juan Chen, Zhao-Qian L |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: